Disseminated keratotic spicules: A rare manifestation in multiple myeloma and successful response to lenalidomide

被引：0
|
作者：
Vivas, Alejandra C.
Chimento, Stacy M.
Herschthal, Jordana
Spock, Christopher
Alonso-Llamazares, Javier
机构：
[1] Vet Affairs Med Ctr Miami, Dept Dermatol, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2013年 / 68卷 / 06期
关键词：
HYPERKERATOTIC SPICULES; FOLLICULAR SPICULES;
D O I：
10.1016/j.jaad.2012.10.023
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：E179 / E180
页数：2
相关论文
共 50 条
  • [21] Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma
    Alonso, Rafael
    Cedena, Maria-Teresa
    Wong, Sandy
    Shah, Nina
    Rios-Tamayo, Rafael
    Moraleda, Jose M.
    Lopez-Jimenez, Javier
    Garcia, Cristina
    Bahri, Natasha
    Valeri, Antonio
    Sanchez, Ricardo
    Collado-Yurrita, Luis
    Martin, Thomas
    Wolf, Jeffrey
    Lahuerta, Juan-Jose
    Martinez-Lopez, Joaquin
    BLOOD ADVANCES, 2020, 4 (10) : 2163 - 2171
  • [22] A Slow Pattern of Response in a Relapsed Multiple Myeloma Patient Treated with Lenalidomide
    Ramirez, G.
    de Llano, M. P.
    Campos, A.
    Rosell, A.
    Garcia, R.
    del Castillo, S.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S88 - S89
  • [23] 5q-syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide
    Ortega, Margarita
    Mallo, Mar
    Sole, Francesc
    Sanchez-Morata, Carmen
    Lopez-Andreoni, Laura
    Martinez-Morgado, Noemi
    Gironella, Mercedes
    Valcarcel, David
    Vallespi, Teresa
    LEUKEMIA RESEARCH, 2013, 37 (10) : 1248 - 1250
  • [24] Response: Lenalidomide therapy and deep-vein thrombosis in multiple myeloma
    Rajkumar, SV
    Gertz, MA
    BLOOD, 2006, 108 (01) : 404 - 404
  • [25] IS A DEEP RESPONSE THE KEY TO SUCCESSFUL TREATMENT OF MULTIPLE MYELOMA?
    Liwing, J.
    Heeg, B. M.
    Karstorp, S.
    Postma, M.
    Silvennoinen, R.
    Putkonen, M.
    Anttila, P.
    Remes, K.
    Abildgaard, N.
    Waage, A.
    Nahi, H.
    HAEMATOLOGICA, 2015, 100 : 92 - 92
  • [26] Case Report: Successful Management of Hepatic Lesions Secondary to Multiple Myeloma (MM) with Lenalidomide and Dexamethasone
    Haidar, Nour A.
    Farhat, Fadi
    Assi, Tarek
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S286 - S287
  • [27] Successful Retreatment with Elotuzumab for Multiple Myeloma with Extramedullary Relapse while Being Treated with Lenalidomide and Dexamethasone
    Oka, Satoko
    Ono, Kazuo
    Nohgawa, Masaharu
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1993 - 1995
  • [28] A miRNA Risk Score for the Prediction of Response to Lenalidomide in Multiple Myeloma (MM) Patients
    Neri, Paola
    Belch, Andrew R.
    Johnson, Jordan
    Gratton, Kathy J.
    Ren, Li
    Duggan, Peter
    Mansoor, Adnan
    Stewart, Douglas A.
    Bahlis, Nizar
    BLOOD, 2011, 118 (21) : 451 - 451
  • [29] Prolonged Lenalidomide Maintenace Therapy Improves the Quality and Deep of Response in Multiple Myeloma
    Alonso Fernandez, Rafael
    Martin, Thomas
    Shah, Nina
    Wong, Sandy
    Rios Tamayo, Rafael
    Maria Moraleda, Jose
    Cabanas, Valentin
    Jose Moreno, Maria
    Javier, Lopez-Jimenez
    Martin, Fernado
    Sanz, Alejandro
    Cedena, Maria-Teresa
    Valeri, Antonio
    Wolf, Jeffrey
    Lahuerta, Juan-Jose
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E285 - E286
  • [30] Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone
    Liang, Shih-Hsin
    Yeh, Su-Peng
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2447 - 2450
12345